|
|
News for:
|
|
For this drug, our server compiled this detailed Chemical Profile.
You will land on a page at the National Library of Medicine where you can drill down to consumer info, research citations, product labelling, toxicology and more. FindingHealthOnline is the world's leading health-pharma search portal and decision engine. It helps you drill down to very detailed information without interference from commercial sites that now dominate Bing, Google, and Yahoo. Near the top of our pages, you will find a link to content that best matches your query.
|
|
|
|
Click the Chemical Profile link above for detailed information.
Visit Betterchem's Drug Index for
- Exclusivity
Patents and market exclusivity
- Drug Information
Prescribing and other
information
- DMFs
Type 2 drug master files
- Databases
Free access to database search
- 21 CFR
FDA regulations for this drug
- Federal Register
FR search results for this drug
- Drug Recalls
For Rx's using this API
|
|
|
| |
FDA Approval Activities for this Drug
Risperdal (risperidone) oral solution & orally disintegrating Johnson & Johnson Pharmaceutical Research & Development, 20-272/S33, 20-588/21 & 21-444/S4 9/10/03 9/25/03
Risperdal (risperidone) orally disintegrating Johnson & Johnson Pharmaceutical Research & Development, 21-444 4/2/03 7/15/03
Risperdal (risperidone) & Solution, Johnson & Johnson Pharmaceutical Research & Development, 20-588/ SE5-015 & 20-272/ SE5-024 11/19/02 11/22/02
Risperdal (risperidone) Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 20-588/ SE5-004 & 20-272/ SE5-008 3/3/02 3/12/02
Risperdal (risperidone) Janssen 20-588/ SE5-005 & 20-272/ SE5-009 7/2/99 7/2/99 7/2/99
Rezulin Indication: Change in labeling to expand Geriatric Use Risperdal (risperidone) Johnson & Johnson Risperdal Consta (risperidone) Johnson & Johnson RISPERIDONE Solution; RISPERDAL JANSSEN 021444 RISPERIDONE RISPERDAL JOHNSON AND JOHNSON
021444 RISPERIDONE RISPERDAL JOHNSON AND JOHNSON
021444 RISPERIDONE RISPERDAL JOHNSON AND JOHNSON
020272 RISPERIDONE 0.2 RISPERDAL JANSSEN 020272 RISPERIDONE RISPERDAL JANSSEN 020272 RISPERIDONE RISPERDAL JANSSEN 020272 RISPERIDONE RISPERDAL JANSSEN 020272 RISPERIDONE RISPERDAL JANSSEN 020272 RISPERIDONE RISPERDAL JANSSEN Risperdal (risperidone) M-TAB Orally Disintegrating, Janssen
Risperdal (risperidone) Johnson & Johnson Risperidone Tablets, Mylan Pharmaceuticals | RISPERDAL M-TAB (risperidone) Orally Disintegrating Tablets, Johnson & Johnson, Formulation Revision | Risperidone Oral Solution, Roxane Labs, Tentative Approval | Risperdal (risperidone) Tablets, Johnson & Johnson, Labeling Revision | Risperdal (risperidone) Oral Solution, Johnson & Johnson, Labeling Revision | Risperdal M-Tab Orally Disintegrating Tablets, Johnson & Johnson, Labeling Revision | Risperdal Consta Injection, Johnson & Johnson, Labeling Revision | Risperidone Oral Solution, Par Pharma, Tentative Approval | Risperidone Oral Solution, Ranbaxy Labs, Tentative Approval | Risperdal Consta (Risperidone) Long-Acting Injection, Johnson & Johnson, Labeling Revision | Risperdal Consta (risperidone) Long-Acting Injection, Johnson & Johnson, Labeling Revsion | Risperdal (risperidone) Tablets, Johnson & Johnson, New or Modified Indication | Risperdal (risperidone) Oral Solution, Johnson & Johnson, New or Modified Indication | Risperdal (risperidone) M-TAB, Johnson & Johnson, New or Modified Indication | Risperidone Oral Solution, Teva Pharma, Tentative Approval | Risperdal Consta (risperidone) Long Acting Injection, Johnson & Johnson, Labeling Revision | Risperdal (risperidone) Consta Long Acting Injection, Johnson & Johnson, Labeling Revision
Visit Betterchem's Drug Index for FDA's latest approval information.
|
|